B. Riley Wealth Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

B. Riley Wealth Advisors’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,000	Closed	-$11	–	2759
2014 Q4	$11	Buy	+2,000	New	+$10.2K	﹤0.01%	2850
2014 Q3	–	Sell	-2,000	Closed	-$13.4K	–	2562
2014 Q2	$13.4K	Buy	+2,000	New	+$12.7K	﹤0.01%	1651

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

B. Riley Wealth Advisors's NWBO Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q1 2015, closing a stake of 2,000 shares — an estimated $11 sold.

B. Riley Wealth Advisors first reported a position in NWBO in Q2 2014 and held it in 2 quarters. The position peaked at $13.4K in Q2 2014. 75 funds tracked by Wall St. Rank hold NWBO as of Q1 2015.

B. Riley Wealth Advisors reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q1 2015 after selling out during the quarter.
B. Riley Wealth Advisors sold 2,000 Northwest Biotherapeutics, Inc. Common stock shares in Q1 2015, an estimated $11.
B. Riley Wealth Advisors first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 2 quarters.
B. Riley Wealth Advisors's Northwest Biotherapeutics, Inc. Common stock position peaked at $13.4K in Q2 2014.
75 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.